Date
|
Paper index
|
Presenter
|
Paper title
|
2015/02/23
|
2014-67
|
BH Kang
|
Relating the metatranscriptome and metagenome of the human gut.
|
2014-66
|
BH Kang
|
Alterations of the human gut microbiome in liver cirrhosis.
|
2014-65
|
HH Kim
|
An integrated catalog of reference genes in the human gut microbiome.
|
2014-64
|
HH Kim
|
Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes.
|
2015/02/16
|
2014-63
|
HH Kim
|
Computational meta'omics for microbial community studies.
|
2014-62
|
HH Kim
|
Functional profiling of the gut microbiome in disease-associated inflammation.
|
2014-61
|
BH Kang
|
Biodiversity and functional genomics in the human microbiome.
|
2014-60
|
BH Kang
|
Chapter 12: Human Microbiome Analysis.
|
2014-59
|
BH Kang
|
Conducting a Microbiome Study.
|
2015/02/09
|
2014-58
|
DS Bae
|
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.
|
2014-57
|
CY Kim
|
Integrating multiple genomic data to predict disease-causing nonsynonymous single nucleotide variants in exome sequencing studies.
|
2014-56
|
ER Kim
|
The Genotype-Tissue Expression (GTEx) project.
|
2015/02/02
|
2014-55
|
T Lee
|
Genetic and epigenetic fine mapping of causal autoimmune disease variants.
|
2014-54
|
CY Kim
|
A general framework for estimating the relative pathogenicity of human genetic variants.
|
2014-53
|
CY Kim
|
A probabilistic model to predict clinical phenotypic traits from genome sequencing.
|
2015/01/26
|
2014-52
|
ER Kim
|
Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution.
|
2014-51
|
KS Kim
|
Principles of regulatory information conservation between mouse and human.
|
2014-50
|
JE Shim
|
Conservation of trans-acting circuitry during mammalian regulatory evolution.
|
2015/01/12
|
2014-49
|
HJ Han
|
Practical guidelines for the comprehensive analysis of ChIP-seq data.
|
2014-48
|
T Lee
|
Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions.
|
2014-47
|
ER Kim
|
Rapid neurogenesis through transcriptional activation in human stem cells.
|
2015/01/05
|
2014-46
|
KS Kim
|
Small RNA changes en route to distinct cellular states of induced pluripotency.
|
2014-45
|
DS Bae
|
Genome-wide characterization of the routes to pluripotency.
|
2014-44
|
DS Bae
|
Divergent reprogramming routes lead to alternative stem-cell states.
|
2014/12/29
|
2014-43
|
HJ Han
|
Global view of enhancer-promoter interactome in human cells.
|
2014-42
|
HJ Han
|
Combining Hi-C data with phylogenetic correlation to predict the target genes of distal regulatory elements in human genome.
|
2014/12/23
|
2014-41
|
CY Kim
|
Super-enhancers in the control of cell identity and disease.
|
2014-40
|
CY Kim
|
Master transcription factors and mediator establish super-enhancers at key cell identity genes.
|
2014/12/09
|
2014-39
|
HH Kim
|
Unraveling the biology of a fungal meningitis pathogen using chemical genetics.
|
2014-38
|
JE Shim
|
A proteome-scale map of the human interactome network.
|
2014-37
|
JE Shim
|
The role of the interactome in the maintenance of deleterious variability in human populations.
|
2014-36
|
HS Shim
|
Integrative annotation of variants from 1092 humans: application to cancer genomics.
|
2014/12/02
|
2014-35
|
HJ Han
|
Mapping functional transcription factor networks from gene expression data.
|
2014-34
|
KS Kim
|
In pursuit of design principles of regulatory sequences.
|
2014/11/25
|
2014-33
|
KS Kim
|
Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease.
|
2014-32
|
HJ Han
|
Developmental fate and cellular maturity encoded in human regulatory DNA landscapes.
|
2014/11/18
|
2014-31
|
SM Yang
|
The 'dnet' approach promotes emerging research on cancer patient survival.
|
2014-30
|
HJ Han
|
Determination and inference of eukaryotic transcription factor sequence specificity.
|
2014/11/11
|
2014-29
|
DS Bae
|
Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles.
|
2014-28
|
HH Kim
|
Dissecting engineered cell types and enhancing cell fate conversion via CellNet.
|
2014-27
|
HH Kim
|
CellNet: network biology applied to stem cell engineering.
|
2014/11/04
|
2014-26
|
HS Shim
|
Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality.
|
2014-25
|
JH Shin
|
Phen-Gen: combining phenotype and genotype to analyze rare disorders.
|
2014/10/28
|
2014-24
|
HJ Han
|
A community effort to assess and improve drug sensitivity prediction algorithms.
|
2014-23
|
HS Shim
|
Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.
|
2014/09/30
|
2014-22
|
JE Shim
|
Network-based stratification of tumor mutations.
|
2014-21
|
KS Kim
|
Synonymous mutations frequently act as driver mutations in human cancers.
|
2014/09/23
|
2014-20
|
CY Kim
|
VarWalker: Personalized Mutation Network Analysis of Putative Cancer Genes from Next-Generation Sequencing Data.
|
2014-19
|
HJ Han
|
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer.
|
2014/09/16
|
2014-18
|
JH Shin
|
Integrated analysis of recurrent properties of cancer genes to identify novel drivers.
|
2014-17
|
AR Cho
|
Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation.
|
2014/09/02
|
2014-16
|
JE Shim
|
A network module-based method for identifying cancer prognostic signatures.
|
2014-15
|
AR Cho
|
Realizing the promise of cancer predisposition genes.
|
2014/08/19
|
2014-14
|
JE Shim
|
Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
|
2014-13
|
HS Shim
|
Mutational landscape and significance across 12 major cancer types.
|
2014/08/12
|
2014-12
|
HS Shim
|
Signatures of mutational processes in human cancer.
|
2014-11
|
HJ Kim
|
Discovery and saturation analysis of cancer genes across 21 tumour types.
|
2014/08/05
|
2014-10
|
CY Kim
|
Comprehensive identification of mutational cancer driver genes across 12 tumor types.
|
2014-9
|
JE Shim
|
IntOGen-mutations identifies cancer drivers across tumor types.
|
2014/07/29
|
2014-8
|
CY Kim
|
Computational approaches to identify functional genetic variants in cancer genomes.
|
2014-7
|
AR Cho
|
Mutational heterogeneity in cancer and the search for new cancer-associated genes.
|
2014-6
|
AR Cho
|
Cancer genomes: discerning drivers from passengers
|
2014/07/22
|
2014-5
|
AR Cho
|
The Cancer Genome Atlas Pan-Cancer analysis project.
|
2014-4
|
AR Cho
|
Cancer genome landscapes.
|
2014-3
|
AR Cho
|
Distinguishing driver and passenger mutations in an evolutionary history categorized by interference.
|
2014/07/15
|
2014-2
|
HJ Han
|
A promoter-level mammalian expression atlas.
|
2014-1
|
HJ Han
|
An atlas of active enhancers across human cell types and tissues.
|